Analysis between Adrenal MRI Mass Size and 1 mg Dexamethasone Suppression Test in Patients with Adrenal Incidentaloma

Authors

  • Pinar Karakaya Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Department of Endocrinology and Metabolic Diseases, Turkey
  • Bulent Yaprak Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Department of Internal Medicine, Turkey
  • Bahar Ozdemir Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Department of Internal Medicine, Turkey
  • Hakan Kocoglu Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Department of Internal Medicine, Turkey

DOI:

https://doi.org/10.31964/mltj.v5i2.223

Keywords:

adrenal incidentaloma, adrenal magnetic resonance imaging mass size, metanephrine, renin

Abstract

This study aimed to investigate the correlation of adrenal magnetic resonance imaging (MRI) mass size and 1 mg dexamethasone suppression test results in patients with adrenal incidentaloma diagnosis. Eighty-six patients (82.6% female) with incidentally discovered adrenal masses, diagnosed and treated in the Department of Endocrinology Bakirkoy Dr. Sadi Konuk Education and Research Hospital between June and August 2017, were included in the analysis. All the patients evaluated for their hormonal functionality. 24-h urinary excretion of cortisol did not correlate with tumor size. But there was a positive correlation between longer adrenal nodule diameter and metanephrine, and there was a negative correlation between shorter adrenal nodule diameter and renin levels. We found that smaller and clinically “silent” tumors often do not demonstrate subclinical hormonal activity.

Downloads

Published

2019-12-20

How to Cite

Karakaya, P., Yaprak, B., Ozdemir, B., & Kocoglu, H. (2019). Analysis between Adrenal MRI Mass Size and 1 mg Dexamethasone Suppression Test in Patients with Adrenal Incidentaloma. Medical Laboratory Technology Journal, 5(2), 108–116. https://doi.org/10.31964/mltj.v5i2.223

Issue

Vol. 5 No. 2 (2019): December

Section

Articles

License

Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.

MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:


BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.